永鼎股份(600105.SH):保持與中科院、核工業西南物理研究院等客户密切合作關係
格隆匯6月18日丨永鼎股份(600105.SH)在投資者互動平台表示,東部超導主營產品是第二代高温超導帶材及超導應用產品。二代高温超導帶材可廣泛應用於能源、電力、交通、醫療、軍事、重大科學工程等領域。報吿期內公司持續擴充產能,優化產線,升級技術,目前產品主要應用於超導感應加熱、超導磁拉單晶、可控核聚變磁體、超導電力等領域,保持與中科院、江西聯創光電、能量奇點、新奧能源、星環聚能、核工業西南物理研究院等客户密切合作關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.